Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection

Details for Australian Patent Application No. 2010315243 (hide)

Owner City of Hope

Inventors Jensen, Michael C.

Agent Spruson & Ferguson

Pub. Number AU-A-2010315243

PCT Pub. Number WO2011/056894

Priority 61/257,567 03.11.09 US

Filing date 3 November 2010

Wipo publication date 12 May 2011

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/16 (2006.01) Mutation or genetic engineering - Hormones

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/056894 Priority application(s): WO2011/056894

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010315245-Methods for treating fatty liver disease

2010315240-Signal cancelling transmit/receive multiloop antenna for a radio frequency identification reader